Evidence map›Paper›PMID 21174458›Full record

SynthesisAnalytical chemistry2011

metaXCMS: second-order analysis of untargeted metabolomics data.

Ralf Tautenhahn, Gary J Patti, Ewa Kalisiak, Takashi Miyamoto, Manuela Schmidt, Fang Yin Lo, Joshua McBee, Nitin S Baliga, Gary Siuzdak

Abstract readMeta-Analysis
In one paragraph

Synthesis in Analytical chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Analytical chemistry · 2021
    Article
  10. Article
  11. Lymphatic Cannulation for Lymph Sampling and Molecular Delivery.Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. New Technologies for Studying Biofilms.Microbiology spectrum · 2015
    Review
  19. Article
  20. Analytical methods in untargeted metabolomics: state of the art in 2015.Frontiers in bioengineering and biotechnology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ralf Tautenhahn
Gary J Patti
Ewa Kalisiak
Takashi Miyamoto
Manuela Schmidt
Fang Yin Lo
Joshua McBee
Nitin S Baliga
Gary Siuzdak

Funding

Therapeutics Core (Page 286)P30MH062261 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 2000 to 2021
$37.7M
Adult Stem Cells for Therapy of Visual DisordersR24EY017540 · NEI · SCRIPPS RESEARCH INSTITUTE, THE · PI FRIEDLANDER, MARTIN · 2007 to 2011
$17.5M
Proteomic Strategies for AIDS and Drug Abuse - HIV and METH CNS SynergyP01DA026146 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 2008 to 2010
$2.9M
NEI NIH HHS R24 EY017540NEI NIH HHS R24 EY017540-04NIA NIH HHS L30 AG0 038036NIA NIH HHS L30 AG038036NIDA NIH HHS P01 DA026146NIDA NIH HHS P01 DA026146-02NIMH NIH HHS P30 MH062261NIMH NIH HHS P30 MH062261-10
6 · The paper itself

Abstract

Mass spectrometry-based untargeted metabolomics often results in the observation of hundreds to thousands of features that are differentially regulated between sample classes. A major challenge in interpreting the data is distinguishing metabolites that are causally associated with the phenotype of interest from those that are unrelated but altered in downstream pathways as an effect. To facilitate this distinction, here we describe new software called metaXCMS for performing second-order ("meta") analysis of untargeted metabolomics data from multiple sample groups representing different models of the same phenotype. While the original version of XCMS was designed for the direct comparison of two sample groups, metaXCMS enables meta-analysis of an unlimited number of sample classes to facilitate prioritization of the data and increase the probability of identifying metabolites causally related to the phenotype of interest. metaXCMS is used to import XCMS results that are subsequently filtered, realigned, and ultimately compared to identify shared metabolites that are up- or down-regulated across all sample groups. We demonstrate the software's utility by identifying histamine as a metabolite that is commonly altered in three different models of pain. metaXCMS is freely available at http://metlin.scripps.edu/metaxcms/.

Indexed as

SoftwareAnimalsMetabolomicsMice

Identifiers

PMID21174458
PMCPMC3654666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.